IIM
IONS icon

INTECH Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

INTECH Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.89M Buy
38,515
+28,913
+301% +$2.28M 0.03% 545
2025
Q4 		$760K Buy
+9,602
New +$723K 0.01% 1281
2025
Q2 		– Sell
-12,207
Closed -$368K – 2567
2025
Q1 		$368K Buy
+12,207
New +$400K ﹤0.01% 1782
2023
Q1 		– Sell
-50,510
Closed -$1.91M – 688
2022
Q4 		$1.91M Sell
50,510
-6,630
-12% -$279K 0.01% 454
2022
Q3 		$2.53M Buy
+57,140
New +$2.41M 0.02% 416

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

INTECH Investment Management's IONS Position: Q1 2026 in Review

INTECH Investment Management increased its Ionis Pharmaceuticals (IONS) stake by 301% in Q1 2026, buying an estimated $2.28M and bringing the position to 38,515 shares worth $2.89M. The position accounts for 0.03% of the portfolio, ranked #545.

INTECH Investment Management first reported a position in IONS in Q3 2022 and has held it in 5 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • INTECH Investment Management held 38,515 shares of Ionis Pharmaceuticals worth $2.89M as of Q1 2026.
  • INTECH Investment Management bought 28,913 Ionis Pharmaceuticals shares in Q1 2026, an estimated $2.28M.
  • Ionis Pharmaceuticals made up 0.03% of INTECH Investment Management's portfolio in Q1 2026, its #545 holding.
  • INTECH Investment Management first reported a position in Ionis Pharmaceuticals in Q3 2022 and has held it in 5 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.